ArticleEthnicity & disease2025
Prevalence of Metabolic Syndrome and Its Components in a Population in the Algerian Sahara.
Article in Ethnicity & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Developing countries, including Algeria, are experiencing an increase in obesity, hypertension, type 2 diabetes, and cardiovascular disease due to changes in diet and lifestyle. Objective: To assess the prevalence of metabolic syndrome and its associated cardiometabolic risk factors among 283 adults in the commune of Aoulef, Algeria. Methods: A descriptive study was conducted between 2015 and 2016 on a random sample of 283 individuals aged 30 to 64 in the commune of Aoulef, located in the far south of Algeria, in the heart of the Sahara. This study included clinical, anthropometric, and biological examinations and used the National Cholesterol Education Program's Adult Treatment Panel III criteria to identify cases of metabolic syndrome. Results: The study found that the prevalence of metabolic syndrome was 18.4%, with rates increasing with age. Women consistently showed a higher prevalence across all age groups (P<.0001), particularly for conditions like abdominal obesity (P<.001), hyperglycemia (P<.009), and low levels of high-density lipoprotein cholesterol, especially among younger women (P<.001). High triglyceride levels were more common in men (P<.001), whereas hypertension increased with age in both sexes (P<.001). The study identified age and marital status as significant risk factors. Individuals aged 50 to 59 were 3 times more likely to develop metabolic syndrome, with the risk quadrupling for women. Additionally, those who were widowed or divorced were also found to be more vulnerable. Conclusions: This study emphasizes the prevalence of metabolic syndrome in southern Algeria, marked by high rates of abdominal obesity and hypertension. Understanding the relationship between this syndrome and its sociodemographic and lifestyle risk factors is crucial for developing effective public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.